Skip to main content

Our purpose is

to make every

pregnancy around

the world safer.

Learn More

Our mission is to develop and make globally available the first therapy targeting a root cause of preeclampsia.

Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.

Learn About Our WorkMeet Our Team

The
Problem

Learn More

A
Breakthrough

Learn More

Our
Science

Learn More

Patient and Survivor Resources

Read our latest news

June 13, 2023

Comanche Biopharma Strengthens Board of Directors with Appointment of Dr. Ann Taylor

Read More

May 12, 2023

Comanche Biopharma Appoints Allyson Felix to Board of Directors

Read More

Contact Us

50 Beharrell St, Unit B
Concord, MA 01742

Contact Us

Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.

Sign up to receive email updates

Translate 🌎 💬